Further research also found that the expression level of CDCA7 correlates with tumor infiltration of immune cells and the expression of immune checkpoint molecules, which may indicate a role for CDCA7 as a new immunotherapeutic target in treating gliomas. Here, CDCA7 is linked to central nervous system cancer.